A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's

A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's

ABSTRACT There is a pressing need for blood biomarkers that can identify Huntington's disease (HD) gene carriers' proximity to manifest disease. We previously examined serial serum neurofilament light (NfL) concentrations in 21 premanifest HD gene carriers and 14 controls over 14 years, fi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Natalia E. Owen, Zanna J. Voysey, Jonathan A. Holbrook, Maura Malpetti, Clara Le Draoulec, Lennart R. B. Spindler, Anna O. G. Goodman, Alpar S. Lazar, Roger A. Barker
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Annals of Clinical and Translational Neurology
Subjects:	blood‐based biomarkers glial fibrillary acidic protein Huntington's disease prognostic biomarkers tau
Online Access:	https://doi.org/10.1002/acn3.70057
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Glial Fibrillary Acidic Protein’s Usefulness as an Astrocyte Biomarker Using the Fully Automated LUMIPULSE<sup>®</sup> System
by: Jo Kamada, et al.
Published: (2024-11-01)

A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
by: Mehri Salari, et al.
Published: (2023-03-01)

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives
by: Ching-Pang Chang, et al.
Published: (2024-10-01)

Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders
by: Udit Sheth, et al.
Published: (2025-03-01)

Predicting ICU Admission in Patients with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
by: Su XH, et al.
Published: (2025-08-01)

Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease
by: Marina Herrero‐Lorenzo, et al.
Published: (2024-10-01)

The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.
by: Sara Samadzadeh, et al.
Published: (2025-03-01)

Prospective Validation of Glial Fibrillary Acidic Protein, d‐Dimer, and Clinical Scales for Acute Large‐Vessel Occlusion Ischemic Stroke Detection
by: Yasir Durrani, et al.
Published: (2024-07-01)

Serum Glial Fibrillary Acidic Protein and S100B Profiles in Severity and Outcome Assessment of Moderate and Severe Head Injury Patients in India
by: Arpana Singh, et al.
Published: (2024-10-01)

Case Reports: Three cases of autoimmune glial fibrillary acidic protein astrocytosis in disguise
by: Wen Zhao, et al.
Published: (2025-07-01)

Bridging neuro-biomarkers and MR imaging: The synergistic role of glial fibrillary acidic protein in early CNS disease diagnosis
by: Mohammad Ghaderian, et al.
Published: (2025-06-01)

Preliminary Evaluation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries with Glial Fibrillary Acidic Protein
by: Mira Keski-Pukkila, et al.
Published: (2024-11-01)

LEVELS OF GLIAL FIBRILLARY ACIDIC PROTEIN IN SERUM AFTER CEREBRAL ISCHEMIA IN THE NEONATAL PERIOD
by: D. V. Blinov
Published: (2016-06-01)

A single-center retrospective analysis of autoimmune glial fibrillary acidic protein astrocytopathy with seizures in children
by: Hongjun Fang, et al.
Published: (2025-06-01)

Plasma concentrations of neurofilament light, p-Tau231 and glial fibrillary acidic protein are elevated in patients with chronic kidney disease and correlate with measured glomerular filtration rate
by: Torunn Axelsson, et al.
Published: (2025-05-01)

Clinical analysis and case series report on autoimmune glial fibrillary acidic protein astrocytopathy presenting with autonomic dysfunction
by: Xiao Ke Wu, et al.
Published: (2025-01-01)

Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseases
by: Wongu Youn, et al.
Published: (2025-05-01)

Diffusion tensor imaging of brain white matter in Huntington gene mutation individuals
by: Roberta Arb Saba, et al.

Serum levels of neurofilament light chain and glial fibrillary acidic protein correlate with disease severity in patients with West Nile virus infection
by: Alessandro Dinoto, et al.
Published: (2025-12-01)

Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as intracranial infectious diseases: case reports and literature review
by: Runhua Bai, et al.
Published: (2025-01-01)

Associations between Sleep Quality and Serum Levels of Neurofilament Light in Individuals with Premanifest Huntington Disease
by: Mitchell Turner, et al.
Published: (2024-06-01)

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury
by: Tyler L. Borko, et al.
Published: (2025-05-01)

Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis
by: Xiaomeng Li, et al.
Published: (2024-12-01)

Nasal Glial Heterotopia: An Unusual Cause of Lump on the Nose in a Child- A Case Report
by: Suchitra Pusapati, et al.
Published: (2025-01-01)

Exploring the effects of moxibustion on cognitive function in rats with multiple cerebral infarctions from the perspective of glial vascular unit repairing
by: Jingji Wang, et al.
Published: (2024-10-01)

Outcomes and physiologic responses associated with ketamine administration after traumatic brain injury in the United States and Canada: a retrospective analysis
by: Austin J. Peters, et al.
Published: (2023-12-01)

Auto-Immune Glial Fibrillary Acidic Protein Astrocytopathy with Active Intrathecal Epstein-Barr Virus: A Single-Center Case Series Report
by: Yu X, et al.
Published: (2025-05-01)

Serum glial fibrillary acidic protein and protein gene product 9.5 for predicting neurological outcomes in cardiac arrest patients with cortical response to somatosensory evoked potentials
by: Chenchen Hang, et al.
Published: (2025-05-01)

Evaluating plasma biomarkers NfL, GFAP, GDF15, and FGF21 as indicators of disease severity in Charcot–Marie Tooth patients
by: Dace Pretkalnina, et al.
Published: (2025-01-01)

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
by: Fernando Rodríguez-Jorge, et al.
Published: (2024-12-01)

Retinal and choroidal morphological changes in Huntington's disease
by: S. N. Svetozarskiy, et al.
Published: (2019-03-01)

Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis
by: Gabriel Sauvage, et al.
Published: (2025-03-01)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
by: Faheem Arshad, et al.
Published: (2025-04-01)

Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis
by: Wangyong Shin, et al.
Published: (2025-04-01)

Use of serum biomarkers in the diagnosis of traumatic brain injury
by: Nadira Nabiyeva Çevik, et al.
Published: (2024-12-01)

Primary ependymoma of the ovary mimicking as yolk sac tumor: A rare case report
by: Trupti S Patel, et al.
Published: (2020-01-01)

Neurological Biomarker Profiles in Royal Canadian Air Force (RCAF) Pilots and Aircrew
by: Shawn G. Rhind, et al.
Published: (2024-12-01)

Creation of a plasma collection for the search of diagnostic biomarkers of glial tumors
by: E. P. Omelchuk, et al.
Published: (2025-01-01)

Free carnitine and branched chain amino acids are not good biomarkers in Huntington’s disease
by: Raphael Machado CASTILHOS, et al.
Published: (2020-03-01)

Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer’s disease and other neurodegenerative dementias in a large Chinese cohort
by: Bin Jiao, et al.
Published: (2025-04-01)